Mitsui & Co. Ltd. has acquired a slightly less than 50% interest and become an investor for GleneaglesCRC Pte. Ltd. for roughly 400 million Yen on 14th January 2010.
This would become a historical milestone for GCRC by having Mitsui as a 49% Stake-Holder, while the 51% Stake will belong to Parkway.
Mitsui is the 2nd largest trading company in Japan. In world wide, Mitsui has presence in every country in the world in a wide range of industries, i.e.: banking, textile, chemicals, consumer goods, telecommunication, aerospace, automobiles, properties, etc..
This would be the first time for Mitsui to invest into a CRO and it aims to use Mitsui’s capital participation as a springboard on expectations of growing demand for clinical trials in Asia.